NeuroEquilibrium proudly announces the appointment of seasoned industry veteran Samit Verma as the Chief Executive Officer. With an illustrious career of over 24 years in FMCG and healthcare, Samit brings a wealth of experience to his new role.

Prior to joining NeuroEquilibrium, Samit held the position of Managing Director at Amplifon India, a subsidiary of Amplifon S.p.A, a renowned Italian multinational corporation and a global frontrunner in the hearing care industry across 29 countries. During his remarkable 12-year journey at Amplifon, Samit played a pivotal role in establishing the business from the ground up, growing it to encompass more than 250 point-of-sales. Samit Verma’s strategic vision and extensive industry expertise make him an invaluable addition to NeuroEquilibrium as the company continues its mission to excel in the field of healthcare and expand across the globe.

Commenting on the latest development, NeuroEquilibrium Founder Rajneesh Bhandari said, “NeuroEquilibrium is going through a fascinating phase of growth both in the domestic market and expanding our global presence, given the vast traction and demand and support from our marquee investors Kotak Ventures, Unicorn India Ventures, and RVCF ventures. We and our investors are delighted to welcome Samit Verma to the NeuroEquilibrium family”.

“Samit comes with a wealth of experience and, most importantly, resonates strongly with our values and ethics in our drive for clinical and technological excellence. Under his able and forward-looking leadership, we are confident that we will scale new heights and build NeuroEquilibrium into a truly global organization with our continued focus on delivering best-in-class clinical excellence for our patients and partners combined with our deep-tech proprietary platform power by AI,” said Dr Anita Bhandari, a renowned neurotologist and co-founder NeuroEquilibrium.

“I’m thrilled to take on the role of CEO at NeuroEquilibrium, a cutting-edge medical technology startup. It’s exciting to lead the world’s largest network of clinics focused on Dizziness, Vertigo, and Balance disorders. I look forward to using my experience to contribute to NeuroEquilibrium’s growth and commitment to providing excellent clinical care.” – Samit Verma, CEO, NeuroEquilibrium.

Founder Rajneesh Bhandari said, “At the heart of our innovative approach and clinical excellence lies our deep-tech platform, which seamlessly integrates cloud technology, computer vision, a clinical decision support system, a remote diagnostic platform, and our proprietary diagnostic equipment and systems. This holistic integration empowers our partner clinics and hospitals to deliver accurate diagnoses and personalized treatment plans, revolutionizing the treatment of vertigo, migraine, dizziness, tinnitus, and balance disorders. We are transforming the lives of millions of individuals suffering from these debilitating conditions globally, leveraging our medical technology and clinical expertise,” he added.

About NeuroEquilibrium

NeuroEquilibrium, a funded medical technology startup, is the world’s largest chain of Dizziness, Vertigo, and Balance clinics. NeuroEquilibrium has over 200 clinics in India in partnership with ENT clinics, Neurology clinics, and corporate hospitals. The company is funded by marquee investors, including Kotak Ventures, RVCF Ventures, and Unicorn India Ventures, to cater to the large number of people who are affected by dizziness and balance disorders—about 15% of the general population faces vertigo and imbalance issues in any given year.